Glucerna is Superior to Ensure for Diabetic Patients
For diabetic patients requiring oral nutritional supplementation, use Glucerna (diabetes-specific formula) rather than Ensure (standard formula), as it provides significantly better glycemic control with lower postprandial glucose excursions and reduced insulin requirements.
Why Glucerna Over Ensure
The evidence consistently demonstrates that diabetes-specific formulas like Glucerna outperform standard formulas across multiple metabolic parameters:
Glycemic Control Benefits
Glucerna produces substantially better postprandial glucose responses compared to standard formulas. In a direct head-to-head comparison, Glucerna demonstrated the lowest incremental area under the curve (AUC) for glucose among meal replacement beverages, including Ensure 1. A comprehensive meta-analysis found that diabetes-specific formulas reduced postprandial glucose rise by 1.03 mmol/L, peak glucose by 1.59 mmol/L, and glucose AUC by 35% compared to standard formulas 2.
Insulin Sensitivity and Requirements
Diabetes-specific formulas significantly improve insulin dynamics:
- Reduced insulin secretion requirements by 26-71% compared to standard formulas 2
- Improved insulin sensitivity (HOMA-IS) with better long-term metabolic impact 3
- Lower insulin AUC with decreased peak insulin levels 3, 4
Mechanism of Action
Glucerna's superior performance stems from its formulation:
- Higher monounsaturated fatty acids (MUFAs) content
- Increased fiber (particularly soluble fiber)
- Modified carbohydrate composition with slower-digesting carbohydrates
- Lower glycemic index overall
These components work synergistically to slow carbohydrate absorption and minimize glucose spikes 3, 2.
Clinical Implications
When to Use Each Formula
Use Glucerna when:
- Patient has type 1 or type 2 diabetes
- Glycemic control is a priority
- Patient requires oral supplementation or tube feeding
- Reducing insulin requirements is beneficial
Standard formulas may be acceptable only when:
- Diabetes-specific formula is genuinely unavailable
- Cost is absolutely prohibitive (though Glucerna may reduce overall costs through better glycemic control and fewer complications 5)
Important Caveats
Monitor individual response: Despite Glucerna's superiority, 22% of subjects still exceeded ADA's recommended 2-hour postprandial glucose targets 1. This means:
- Check postprandial glucose levels after initiating any formula
- Adjust diabetes medications accordingly
- Don't assume any formula eliminates the need for glucose monitoring
Carbohydrate content matters: The glucose response correlates directly with grams of carbohydrate in the formula 6. When comparing products, consider total carbohydrate load, not just formula type.
Guideline Context
While the 2014 ADA nutrition guidelines 7 don't specifically address enteral formulas versus standard supplements, they emphasize individualized nutrition therapy and carbohydrate quality over quantity—principles that support using diabetes-specific formulas. The guideline's focus on reducing postprandial glucose excursions and cardiovascular risk aligns with choosing formulas that minimize glycemic variability.
Bottom Line Algorithm
- First-line choice: Glucerna or equivalent diabetes-specific formula
- Monitor: Check postprandial glucose at 2 hours after formula initiation
- Adjust medications: Titrate insulin/oral agents based on actual glucose response
- If glucose targets not met: Consider further medication adjustment rather than switching to standard formula
- Only use standard formula: When diabetes-specific formula is truly unavailable, then increase glucose monitoring frequency
The evidence is clear and consistent: diabetes-specific formulas like Glucerna provide measurably better outcomes for diabetic patients requiring nutritional supplementation 1, 3, 2.